Unity Biotechnology

Organization

Brisbane, CA, US

Ticker Symbols

NASDAQ:UBX

PHARMACEUTICAL PREPARATIONS
Business Address
3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Mailing Address
3280 BAYSHORE BOULEVARD BRISBANE CA 94005
State Location
CA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Treating liver disease by selectively eliminating senescent cells
- Patent number 11,980,616
- Issue date May 14, 2024
- Mayo Foundation for Medical Education and Research
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating cardiovascular disease by selectively eliminating senescen...
- Patent number 11,963,957
- Issue date Apr 23, 2024
- Mayo Foundation for Medical Education and Research
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating retinal vasculopathies
- Patent number 11,951,115
- Issue date Apr 9, 2024
- Unity Biotechnology, Inc.
- Sharon Klier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting pathological angiogenesis
- Patent number 11,865,123
- Issue date Jan 9, 2024
- Unity Biotechnology, Inc.
- Pam Tsuruda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating cognitive decline and other neurodegenerative conditions b...
- Patent number 11,351,167
- Issue date Jun 7, 2022
- Buck Institute for Research on Aging
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of inhibiting pathological angiogenesis
- Patent number 11,129,838
- Issue date Sep 28, 2021
- Unity Biotechnology, Inc.
- Pam Tsuruda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acylsulfonamide derivatives for treating senescence-associated dise...
- Patent number 11,111,259
- Issue date Sep 7, 2021
- UNITY BIOTECHNOLOGY, INC.
- Bradley Backes
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Acyl sulfonamides that are Bcl family antagonists for use in clinic...
- Patent number 10,981,892
- Issue date Apr 20, 2021
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Conjugates that are configured for targeted delivery of therapeutic...
- Patent number 10,745,445
- Issue date Aug 18, 2020
- Unity Biotechnology, Inc.
- Shayne Squires
- G01 - MEASURING TESTING
Information Patent Grant
Phospholidines that are Bcl family antagonists for use in clinical...
- Patent number 10,745,429
- Issue date Aug 18, 2020
- UNITY BIOTECHNOLOGY, INC.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphonamidates that are Bcl family antagonists for use in clinica...
- Patent number 10,738,042
- Issue date Aug 11, 2020
- UNITY BIOTECHNOLOGY, INC.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyl sulfonamides that are Bcl family antagonists for use in clinic...
- Patent number 10,717,722
- Issue date Jul 21, 2020
- UNITY BIOTECHNOLOGY, INC.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyl phosphonamidates and acyl benzylamines that are Bcl family ant...
- Patent number 10,703,745
- Issue date Jul 7, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide-based proteasome inhibitors for treating conditions mediate...
- Patent number 10,689,416
- Issue date Jun 23, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Technology to inhibit vascular changes that lead to vision loss in...
- Patent number 10,588,916
- Issue date Mar 17, 2020
- UNITY BIOTECHNOLOGY, INC.
- Pam Tsuruda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Composition comprising a gene vector that selectively depletes P16...
- Patent number 10,550,378
- Issue date Feb 4, 2020
- UNITY BIOTECHNOLOGY, INC.
- Serge Lichtsteiner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Removing senescent cells from a mixed cell population or tissue usi...
- Patent number 10,517,866
- Issue date Dec 31, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptide-based proteasome inhibitors for treating conditions mediate...
- Patent number 10,519,197
- Issue date Dec 31, 2019
- UNITY BIOTECHNOLOGY, INC.
- Ryan Hudson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions of matter for treatment of ophthalmic conditions by se...
- Patent number 10,478,432
- Issue date Nov 19, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Unit dose of an aryl sulfonamide that is effective for treating eye...
- Patent number 10,478,433
- Issue date Nov 19, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chemical entities that kill senescent cells for use in treating age...
- Patent number 10,426,788
- Issue date Oct 1, 2019
- UNITY BIOTECHNOLOGY, INC.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for killing senescent cells and for treati...
- Patent number 10,413,542
- Issue date Sep 17, 2019
- Buck Institute for Research on Aging
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Replication conditional virus that specifically kills senescent cells
- Patent number 10,378,002
- Issue date Aug 13, 2019
- UNITY BIOTECHNOLOGY, INC.
- Serge Lichtsteiner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treating atherosclerosis by removing senescent foam cell macrophage...
- Patent number 10,328,058
- Issue date Jun 25, 2019
- Mayo Foundation for Medical Education and Research
- Darren J. Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalm...
- Patent number 10,328,073
- Issue date Jun 25, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chiral synthesis method for producing cis-imidazoline compounds for...
- Patent number 10,329,279
- Issue date Jun 25, 2019
- UNITY BIOTECHNOLOGY, INC.
- Thomas W. von Geldern
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunogenic compositions for inducing an immune response for elimin...
- Patent number 10,279,018
- Issue date May 7, 2019
- UNITY BIOTECHNOLOGY, INC.
- Alain Philippe Vasserot
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treating pulmonary conditions by selectively removing senescent cel...
- Patent number 10,258,618
- Issue date Apr 16, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of optimizing conditions for selectively removing a pluralit...
- Patent number 10,213,426
- Issue date Feb 26, 2019
- UNITY BIOTECHNOLOGY, INC.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical entities that kill senescent cells for use in treating age...
- Patent number 10,195,213
- Issue date Feb 5, 2019
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Antibodies Directed to TIE-2 and Methods of Use
- Publication number 20240392012
- Publication date Nov 28, 2024
- Unity Biotechnology, Inc.
- Jason Damiano
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Treating Retinal Vasculopathies
- Publication number 20240342202
- Publication date Oct 17, 2024
- Unity Biotechnology, Inc.
- Sharon Klier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Treating Retinal Vasculopathies
- Publication number 20240245680
- Publication date Jul 25, 2024
- Unity Biotechnology, Inc.
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of a Senescence-Associated Ocular Disease or Disorder Usi...
- Publication number 20240115563
- Publication date Apr 11, 2024
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Crystalline Solid Meglumine Salt Inhibitor of BCL and Methods of Ma...
- Publication number 20240043456
- Publication date Feb 8, 2024
- Unity Biotechnology, Inc.
- Liang Liao
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Treating Retinal Vasculopathies
- Publication number 20220331345
- Publication date Oct 20, 2022
- Unity Biotechnology, Inc.
- Sharon Klier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MED...
- Publication number 20220096466
- Publication date Mar 31, 2022
- Buck Institute for Research and Aging
- Shankar J. Chinta
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of Inhibiting Pathological Angiogenesis
- Publication number 20220072015
- Publication date Mar 10, 2022
- Unity Biotechnology, Inc.
- Pam Tsuruda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20220017485
- Publication date Jan 20, 2022
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Killing Senescent Cells And Treating Senescence-Associated Conditio...
- Publication number 20210379078
- Publication date Dec 9, 2021
- Unity Biotechnology, Inc.
- Pieter Bas Kwak
- G01 - MEASURING TESTING
Information Patent Application
TREATING CARDIOVASCULAR DISEASE BY SELECTIVELY ELIMINATING SENESCEN...
- Publication number 20210169875
- Publication date Jun 10, 2021
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING LIVER DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS
- Publication number 20210169876
- Publication date Jun 10, 2021
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO TIE-2 AND METHODS OF USE
- Publication number 20210155697
- Publication date May 27, 2021
- Unity Biotechnology, Inc.
- Jason Damiano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phospholidines that are Bcl Family Antagonists for Use in Clinical...
- Publication number 20210070788
- Publication date Mar 11, 2021
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...
- Publication number 20210030752
- Publication date Feb 4, 2021
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Phosphonamidates that are BCL Family Antagonists for Use in Clinica...
- Publication number 20200399259
- Publication date Dec 24, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20200392105
- Publication date Dec 17, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITION COMPRISING A GENE VECTOR THAT SELECTIVELY DEPLETES P16...
- Publication number 20200370029
- Publication date Nov 26, 2020
- Unity Biotechnology, Inc.
- Serge Lichtsteiner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways...
- Publication number 20200360386
- Publication date Nov 19, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...
- Publication number 20200354336
- Publication date Nov 12, 2020
- Unity Biotechnology, Inc.
- Nick Vlahakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Remo...
- Publication number 20200338094
- Publication date Oct 29, 2020
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS...
- Publication number 20200338097
- Publication date Oct 29, 2020
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20200317640
- Publication date Oct 8, 2020
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISE...
- Publication number 20200291050
- Publication date Sep 17, 2020
- Unity Biotechnology, Inc.
- Bradley Backes
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Inhibiting Pathological Angiogenesis
- Publication number 20200253991
- Publication date Aug 13, 2020
- Unity Biotechnology, Inc.
- Pam Tsuruda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...
- Publication number 20200199103
- Publication date Jun 25, 2020
- Unity Biotechnology, Inc.
- Nick Vlahakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE...
- Publication number 20200069703
- Publication date Mar 5, 2020
- Unity Biotechnology, Inc.
- Nathaniel David
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...
- Publication number 20200030323
- Publication date Jan 30, 2020
- BUCK INSTITUTE FOR RESEARCH ON AGING
- Remi-Martin Laberge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Peptide-based proteasome inhibitors for treating conditions mediate...
- Publication number 20200002378
- Publication date Jan 2, 2020
- Unity Biotechnology, Inc.
- Ryan Hudson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...
- Publication number 20190382371
- Publication date Dec 19, 2019
- Unity Biotechnology, Inc.
- Anne-Marie Beausoleil
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
88054678 - UNITY BIOTECHNOLOGY
- Serial number 88054678
- Registration number 5720488
- Filing date Jul 26, 2018
- UNITY BIOTECHNOLOGY, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88054680 - UNITY
- Serial number 88054680
- Registration number 5702115
- Filing date Jul 26, 2018
- UNITY BIOTECHNOLOGY, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86385592 - UNITY BIOTECHNOLOGY
- Serial number 86385592
- Registration number 5481287
- Filing date Sep 4, 2014
- Cenexys, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86385598 - UNITY BIOTECHNOLOGY
- Serial number 86385598
- Registration number 5481288
- Filing date Sep 4, 2014
- Cenexys, Inc.
- 5 - Pharmaceutical and veterinary preparations

Unity Biotechnology

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Treating liver disease by selectively eliminating senescent cells

Treating cardiovascular disease by selectively eliminating senescen...

Methods of treating retinal vasculopathies

Methods of inhibiting pathological angiogenesis

Treating cognitive decline and other neurodegenerative conditions b...

Methods of inhibiting pathological angiogenesis

Acylsulfonamide derivatives for treating senescence-associated dise...

Acyl sulfonamides that are Bcl family antagonists for use in clinic...

Conjugates that are configured for targeted delivery of therapeutic...

Phospholidines that are Bcl family antagonists for use in clinical...

Phosphonamidates that are Bcl family antagonists for use in clinica...

Acyl sulfonamides that are Bcl family antagonists for use in clinic...

Acyl phosphonamidates and acyl benzylamines that are Bcl family ant...

Peptide-based proteasome inhibitors for treating conditions mediate...

Technology to inhibit vascular changes that lead to vision loss in...

Composition comprising a gene vector that selectively depletes P16...

Removing senescent cells from a mixed cell population or tissue usi...

Peptide-based proteasome inhibitors for treating conditions mediate...

Compositions of matter for treatment of ophthalmic conditions by se...

Unit dose of an aryl sulfonamide that is effective for treating eye...

Chemical entities that kill senescent cells for use in treating age...

Methods and compositions for killing senescent cells and for treati...

Replication conditional virus that specifically kills senescent cells

Treating atherosclerosis by removing senescent foam cell macrophage...

Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalm...

Chiral synthesis method for producing cis-imidazoline compounds for...

Immunogenic compositions for inducing an immune response for elimin...

Treating pulmonary conditions by selectively removing senescent cel...

Method of optimizing conditions for selectively removing a pluralit...

Chemical entities that kill senescent cells for use in treating age...

Patents Applicationslast 30 patents

Antibodies Directed to TIE-2 and Methods of Use

Methods of Treating Retinal Vasculopathies

Methods of Treating Retinal Vasculopathies

Treatment of a Senescence-Associated Ocular Disease or Disorder Usi...

Crystalline Solid Meglumine Salt Inhibitor of BCL and Methods of Ma...

Methods of Treating Retinal Vasculopathies

TREATMENT OF PARKINSON'S DISEASE AND OTHER CONDITIONS CAUSED OR MED...

Methods of Inhibiting Pathological Angiogenesis

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

Killing Senescent Cells And Treating Senescence-Associated Conditio...

TREATING CARDIOVASCULAR DISEASE BY SELECTIVELY ELIMINATING SENESCEN...

TREATING LIVER DISEASE BY SELECTIVELY ELIMINATING SENESCENT CELLS

ANTIBODIES DIRECTED TO TIE-2 AND METHODS OF USE

Phospholidines that are Bcl Family Antagonists for Use in Clinical...

TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...

Phosphonamidates that are BCL Family Antagonists for Use in Clinica...

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

COMPOSITION COMPRISING A GENE VECTOR THAT SELECTIVELY DEPLETES P16...

Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways...

Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...

Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Remo...

USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS...

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

ACYLSULFONAMIDE DERIVATIVES FOR TREATING SENESCENCE-ASSOCIATED DISE...

Methods of Inhibiting Pathological Angiogenesis

Treatment of Lung Diseases Using Pharmaceutical Agents that Elimina...

CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE...

TREATING COGNITIVE DECLINE AND OTHER NEURODEGENERATIVE CONDITIONS B...

Peptide-based proteasome inhibitors for treating conditions mediate...

Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinic...

Trademarklast 30 trademarks

88054678 - UNITY BIOTECHNOLOGY

88054680 - UNITY

86385592 - UNITY BIOTECHNOLOGY

86385598 - UNITY BIOTECHNOLOGY